Biomarkers for Pancreatic Neuroendocrine Neoplasms (PanNENs) Management—An Updated Review

Biomarkers for Pancreatic Neuroendocrine Neoplasms (PanNENs) Management—An Updated Review

Pancreatic neuroendocrine tumors (PanNENs) are rare sporadic cancers or develop as part of hereditary syndromes. PanNENs can be both functioning and non-functioning based on whether they produce bioactive peptides. Some PanNENs are well differentiated while others—poorly. Symptoms, thus, depend on b...

Full description

Bibliographic Details
Main Authors: Martine Bocchini, Fabio Nicolini, Stefano Severi, Alberto Bongiovanni, Toni Ibrahim, Giorgia Simonetti, Ilaria Grassi, Massimiliano Mazza
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-05-01
Series:Frontiers in Oncology
Subjects:
pancreatic tumor
pancreatic neuroendocrine tumor
biomarker
neuroendocrine syndrome
FDG (18F-fluorodeoxyglucose)-PET/CT
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2020.00831/full

Internet

https://www.frontiersin.org/article/10.3389/fonc.2020.00831/full

Similar Items